Skip to content

Foundayo (orforglipron): the once-daily weight loss pill

By the glp1doses editorial team
Every number is checked against FDA labels and official price pages. How we check

The short answer

Foundayo (orforglipron) is a once-daily GLP-1 weight loss pill from Eli Lilly. It's approved for long-term weight reduction in adults with obesity, or with overweight and at least one weight-related condition. The lowest self-pay price is $149 a month for the 0.8 mg starting dose through LillyDirect, rising to $299 at the highest doses.

Source: LillyDirect self-pay

Key takeaways

  • Foundayo is one tablet a day, with or without food. Swallow it whole, and never take two in a day.
  • Paying cash? LillyDirect self-pay starts at $149 a month for the 0.8 mg starting dose.
  • On 14.5 mg or 17.2 mg through LillyDirect, refill within 45 days of your last fill or the regular price applies.
  • If you miss 7 or more doses in a row, ask your prescriber which lower dose to restart at.
  • On Medicare? Eligible Part D patients can get Foundayo through the GLP-1 Bridge for a $50 monthly copay.

Foundayo at a glance

Foundayo facts from the FDA label and verified prices
Active ingredientorforglipron
MakerEli Lilly and Company
FDA-approved uses
  • reduce excess body weight and maintain weight reduction long term in adults with obesity, or overweight with at least one weight-related comorbid condition
Forms and strengths
  • Tablet (once daily): 0.8, 2.5, 5.5, 9, 14.5, 17.2 mg
Medicare GLP-1 BridgeCovered forms: Tablet (once daily)
Cheapest verified self-pay$299 per fill at 17.2 mg, LillyDirect self-pay (lilly.com)
With commercial insurance that covers it$25 per fill at 17.2 mg, Manufacturer savings card (commercial insurance, drug covered) (lilly.com)
On Medicare Part D$50 per fill at 17.2 mg, Medicare GLP-1 Bridge (medicare.gov)
LabelRevised: 7/2026 (DailyMed version 10)

Foundayo dose schedule from the label

Put it on a calendar with the titration schedule builder. Only your prescriber decides when, and whether, your dose changes.

See every price

Every verified Foundayo price

Foundayo: price by where you buy, form and dose
Where you buyForm · dosePriceConditionsSource
Medicare GLP-1 BridgeTablet (once daily) · All strengths$50/month
Conditions

Medicare GLP-1 Bridge demonstration, July 1, 2026 through December 31, 2027. For adults 18 or older with Medicare Part D drug coverage (standalone PDP, MA-PD, SNP, EGWP or LI NET) who meet the BMI criteria when starting GLP-1 therapy (BMI 35+, or BMI 30+ with diastolic heart failure, uncontrolled hypertension or CKD stage 3a+, or BMI 27+ with prediabetes, prior heart attack or stroke, or symptomatic peripheral artery disease). Not for people already getting GLP-1s through their Part D plan, or using the drug for type 2 diabetes, sleep apnea or fatty liver disease. Prior authorization required (valid through December 31, 2027 unless you change drugs). $50 copay per one-month supply (28 or 30 days); it does not count toward the Part D deductible or out-of-pocket limit and cannot be reduced by Extra Help. Foundayo tablets are covered at every strength; fills are a 30-day supply.

medicare.gov
Manufacturer savings cardcommercial insurance, drug coveredTablet (once daily) · All strengths$25/month
Conditions

Commercial drug insurance that covers Foundayo. Pay as little as $25 for a 1-, 2- or 3-month fill; maximum savings $100 per 1-month, $200 per 2-month or $300 per 3-month fill, and $1,000 per calendar year; up to 10 fills per year. Month is 30 days. Government beneficiaries excluded. Card expires 12/31/2026.

lilly.com
Manufacturer savings cardcommercial insurance, drug not coveredTablet (once daily) · 0.8 mg$149/month
Conditions

Commercial drug insurance that does not cover Foundayo. Pay as low as $149 per 1-month (30-day) fill, maximum monthly savings $520. Up to 10 fills per calendar year. Government beneficiaries excluded. Card expires 12/31/2026.

lilly.com
Manufacturer savings cardcommercial insurance, drug not coveredTablet (once daily) · 2.5 mg$149/month
Conditions

Commercial drug insurance that does not cover Foundayo. Pay as low as $149 per 1-month (30-day) fill, maximum monthly savings $520. Temporarily reduced price through December 31, 2026. Up to 10 fills per calendar year. Government beneficiaries excluded. Card expires 12/31/2026.

lilly.com
Manufacturer savings cardcommercial insurance, drug not coveredTablet (once daily) · 5.5 mg$199/month
Conditions

Commercial drug insurance that does not cover Foundayo. Pay as low as $199 per 1-month (30-day) fill, maximum monthly savings $470. Temporarily reduced price through December 31, 2026. Up to 10 fills per calendar year. Government beneficiaries excluded. Card expires 12/31/2026.

lilly.com
Manufacturer savings cardcommercial insurance, drug not coveredTablet (once daily) · 9 mg$299/month
Conditions

Commercial drug insurance that does not cover Foundayo. Pay as low as $299 per 1-month (30-day) fill, maximum monthly savings $370. Up to 10 fills per calendar year. Government beneficiaries excluded. Card expires 12/31/2026.

lilly.com
Manufacturer savings cardcommercial insurance, drug not coveredTablet (once daily) · 14.5 mg$299/month
Conditions

Commercial drug insurance that does not cover Foundayo. Pay as low as $299 per 1-month (30-day) fill, maximum monthly savings $370. The $299 price applies to your first fill and to refills within 45 days of the prior fill; otherwise the regular price of $349 applies. Up to 10 fills per calendar year. Government beneficiaries excluded. Card expires 12/31/2026.

lilly.com
Manufacturer savings cardcommercial insurance, drug not coveredTablet (once daily) · 17.2 mg$299/month
Conditions

Commercial drug insurance that does not cover Foundayo. Pay as low as $299 per 1-month (30-day) fill, maximum monthly savings $370. The $299 price applies to your first fill and to refills within 45 days of the prior fill; otherwise the regular price of $349 applies. Up to 10 fills per calendar year. Government beneficiaries excluded. Card expires 12/31/2026.

lilly.com
TrumpRxTablet (once daily) · 0.8 mg$149/month
Conditions

Out-of-pocket (self-pay) price listed on TrumpRx.gov for 30 tablets; orders go through LillyDirect, which confirms eligibility. TrumpRx lists the original (list) price as $649.00.

trumprx.gov
TrumpRxTablet (once daily) · 2.5 mg$149/month
Conditions

Out-of-pocket (self-pay) price listed on TrumpRx.gov for 30 tablets; orders go through LillyDirect, which confirms eligibility. Temporarily reduced through December 31, 2026; regular price $199. TrumpRx lists the original (list) price as $649.00.

trumprx.gov
TrumpRxTablet (once daily) · 5.5 mg$199/month
Conditions

Out-of-pocket (self-pay) price listed on TrumpRx.gov for 30 tablets; orders go through LillyDirect, which confirms eligibility. Temporarily reduced through December 31, 2026; regular price $299. TrumpRx lists the original (list) price as $649.00.

trumprx.gov
TrumpRxTablet (once daily) · 9 mg$299/month
Conditions

Out-of-pocket (self-pay) price listed on TrumpRx.gov for 30 tablets; orders go through LillyDirect, which confirms eligibility. TrumpRx lists the original (list) price as $649.00.

trumprx.gov
TrumpRxTablet (once daily) · 14.5 mg$299/month
Conditions

Out-of-pocket (self-pay) price listed on TrumpRx.gov for 30 tablets; orders go through LillyDirect, which confirms eligibility. Price applies to your first fill at this dose or refills within 45 days of the prior delivery/receipt; refills more than 45 days later cost $349. TrumpRx lists the original (list) price as $649.00.

trumprx.gov
TrumpRxTablet (once daily) · 17.2 mg$299/month
Conditions

Out-of-pocket (self-pay) price listed on TrumpRx.gov for 30 tablets; orders go through LillyDirect, which confirms eligibility. Price applies to your first fill at this dose or refills within 45 days of the prior delivery/receipt; refills more than 45 days later cost $349. TrumpRx lists the original (list) price as $649.00.

trumprx.gov
LillyDirect self-payTablet (once daily) · 0.8 mg$149/month
Conditions

Self-pay only through LillyDirect (no insurance used). Prescription required; month is 30 days; additional taxes and fees may apply; program is not insurance and Lilly may change or cancel it.

lilly.com
LillyDirect self-payTablet (once daily) · 2.5 mg$149/month
Conditions

Self-pay only through LillyDirect (no insurance used). Prescription required; month is 30 days; additional taxes and fees may apply; program is not insurance and Lilly may change or cancel it. Temporarily reduced price through December 31, 2026; the regular price for this dose is $199 per month.

lilly.com
LillyDirect self-payTablet (once daily) · 5.5 mg$199/month
Conditions

Self-pay only through LillyDirect (no insurance used). Prescription required; month is 30 days; additional taxes and fees may apply; program is not insurance and Lilly may change or cancel it. Temporarily reduced price through December 31, 2026; the regular price for this dose is $299 per month.

lilly.com
LillyDirect self-payTablet (once daily) · 9 mg$299/month
Conditions

Self-pay only through LillyDirect (no insurance used). Prescription required; month is 30 days; additional taxes and fees may apply; program is not insurance and Lilly may change or cancel it.

lilly.com
LillyDirect self-payTablet (once daily) · 14.5 mg$299/month
Conditions

Self-pay only through LillyDirect (no insurance used). Prescription required; month is 30 days; additional taxes and fees may apply; program is not insurance and Lilly may change or cancel it. Foundayo Self-Pay Journey Program price: applies to your first fill at this dose and to refills purchased within 45 days of the delivery/receipt of the previous fill; if the refill is more than 45 days late the regular price of $349 per month applies.

lilly.com
LillyDirect self-payTablet (once daily) · 17.2 mg$299/month
Conditions

Self-pay only through LillyDirect (no insurance used). Prescription required; month is 30 days; additional taxes and fees may apply; program is not insurance and Lilly may change or cancel it. Foundayo Self-Pay Journey Program price: applies to your first fill at this dose and to refills purchased within 45 days of the delivery/receipt of the previous fill; if the refill is more than 45 days late the regular price of $349 per month applies.

lilly.com
Hims & HersTablet (once daily) · All strengths$149/month
Conditions

'From' price; medication only. Requires Hims Weight Loss Membership ($39 first month, then $149/month), billed separately. Cash-pay; insurance not required. Not available in all 50 states.

hims.com
Mochi HealthTablet (once daily) · All strengths$149/month
Conditions

'As low as' price; plus Mochi Health membership ($79/month, first month $0 promo for new subscribers). Medication not included in membership; availability and pricing vary by state.

joinmochi.com
RoTablet (once daily) · 0.8 mg$149/month
Conditions

Plus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx.

ro.co
SesameTablet (once daily) · 0.8 mg$149/month
Conditions

Manufacturer self-pay price passed through by Sesame ('No markups on medication'); plus Success by Sesame subscription ($99/mo month-to-month, as low as $59/mo annual). Foundayo self-pay offer valid Sep 1, 2026 - Dec 31, 2026.

sesamecare.com
RoTablet (once daily) · 2.5 mg$149/month
Conditions

Plus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. Limited-time offer: regular $199; sign up by Dec 31, 2026 to qualify.

ro.co
SesameTablet (once daily) · 2.5 mg$149/month
Conditions

Manufacturer self-pay price passed through by Sesame ('No markups on medication'); plus Success by Sesame subscription ($99/mo month-to-month, as low as $59/mo annual). Foundayo self-pay offer valid Sep 1, 2026 - Dec 31, 2026. Previously $199.

sesamecare.com
RoTablet (once daily) · 5.5 mg$199/month
Conditions

Plus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. Limited-time offer: regular $299; sign up by Dec 31, 2026 to qualify.

ro.co
SesameTablet (once daily) · 5.5 mg$199/month
Conditions

Manufacturer self-pay price passed through by Sesame ('No markups on medication'); plus Success by Sesame subscription ($99/mo month-to-month, as low as $59/mo annual). Foundayo self-pay offer valid Sep 1, 2026 - Dec 31, 2026. Previously $299.

sesamecare.com
RoTablet (once daily) · 9 mg$299/month
Conditions

Plus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx.

ro.co
SesameTablet (once daily) · 9 mg$299/month
Conditions

Manufacturer self-pay price passed through by Sesame ('No markups on medication'); plus Success by Sesame subscription ($99/mo month-to-month, as low as $59/mo annual). Foundayo self-pay offer valid Sep 1, 2026 - Dec 31, 2026.

sesamecare.com
RoTablet (once daily) · 14.5 mg$299/month
Conditions

Plus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. 'With offer' price under a manufacturer offer for 14.5 mg and higher doses (Save $150).

ro.co
SesameTablet (once daily) · 14.5 mg$299/month
Conditions

Manufacturer self-pay price passed through by Sesame ('No markups on medication'); plus Success by Sesame subscription ($99/mo month-to-month, as low as $59/mo annual). Foundayo self-pay offer valid Sep 1, 2026 - Dec 31, 2026. $299 is the Foundayo Self-Pay Journey Program price (refill within 45 days); standard price $349.

sesamecare.com
RoTablet (once daily) · 17.2 mg$299/month
Conditions

Plus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. 'With offer' price under a manufacturer offer for 14.5 mg and higher doses (Save $150).

ro.co
SesameTablet (once daily) · 17.2 mg$299/month
Conditions

Manufacturer self-pay price passed through by Sesame ('No markups on medication'); plus Success by Sesame subscription ($99/mo month-to-month, as low as $59/mo annual). Foundayo self-pay offer valid Sep 1, 2026 - Dec 31, 2026. $299 is the Foundayo Self-Pay Journey Program price (refill within 45 days); standard price $349.

sesamecare.com
List priceTablet (once daily) · All strengths$649/month
Conditions

List price (WAC) per month for a 30-day supply (once daily).

pricinginfo.lilly.com

Foundayo is the first pill form of a GLP-1 medicine from Eli Lilly. Its generic name is orforglipron. Most people want to know three things: what it costs, how you take it, and how it compares with injections and with the other weight loss pill. This guide answers those from the FDA label (Revised: 7/2026 (DailyMed version 10)) and from the prices that Lilly, the government and telehealth providers publish.

What is Foundayo approved for?

Foundayo is approved to reduce excess body weight and keep it off long term in adults with obesity, or with overweight and at least one weight-related condition. The Medication Guide says to use it with a reduced-calorie diet and increased physical activity.

The label sets several limits:

  • Using Foundayo together with another GLP-1 receptor agonist isn’t recommended.
  • Its safety and effectiveness haven’t been established in children.
  • It isn’t recommended for people with severe gastroparesis (a condition where the stomach empties very slowly) or with severe liver impairment (Child-Pugh Class C, the most serious group on a standard liver scale).

Foundayo isn’t approved for type 2 diabetes. People with type 2 diabetes were included in one of its weight trials, and the label carries warnings specific to them, covered below.

How much weight do people lose on Foundayo?

The label reports two trials, and each one measured the average percent change in body weight after 72 weeks. The label notes that these trials used an investigational orforglipron formulation, and it presents the results as the equivalent once-daily Foundayo doses.

  • Trial 1 (adults without diabetes): mean (average) body weight changed by -7.4% at 5.5 mg, -8.3% at 9 mg and -11.1% at 17.2 mg, versus -2.1% with placebo.
  • Trial 2 (adults with type 2 diabetes): the change was -5.1% at 5.5 mg, -7% at 9 mg and -9.6% at 17.2 mg, versus -2.5% with placebo.

These are averages for trial groups, not a prediction for one person.

How do you take Foundayo?

The label’s instructions are short:

  • Take one tablet by mouth once daily, with or without food.
  • Swallow the tablet whole. Don’t break, crush or chew it.
  • Don’t take more than one tablet per day.

Foundayo comes in bottles of 30 tablets, so one bottle is a 30-day supply.

Foundayo slows stomach emptying, so the label says it may affect how your body absorbs other medicines you take by mouth. Tell your prescriber and pharmacist about everything you take. The label names some specific interactions:

  • Certain medicines that affect the CYP3A4 enzyme. This enzyme helps your body break down many medicines. With a strong CYP3A4 inhibitor (a medicine that slows the enzyme), the maximum Foundayo dose is 9 mg once daily. Avoid strong CYP3A4 inhibitors that also inhibit OATP1B, and avoid strong CYP3A4 inducers (medicines that speed the enzyme up). Your pharmacist can tell you whether a medicine you take falls into one of these groups.
  • Simvastatin. The label says not to exceed simvastatin 20 mg once daily when you take it with Foundayo.
  • Insulin and sulfonylureas. Your prescriber may need to lower the dose of these when you start Foundayo.
  • Birth control pills. The label advises switching to a non-oral contraceptive or adding a barrier method for 30 days after starting Foundayo and for 30 days after each dose increase. Hormonal contraceptives that you don’t take by mouth shouldn’t be affected.

What doses does Foundayo come in?

Foundayo tablets come in 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, 17.2 mg. The unusual numbers are simply the strengths the label lists. The schedule has two required steps and then optional ones:

  1. 0.8 mg once daily to start, for at least 30 days.
  2. 2.5 mg once daily, for at least 30 days.
  3. 5.5 mg once daily.
  4. From here the dose may go up to the next level (9 mg, then 14.5 mg, then 17.2 mg), each after at least 30 days on the current dose, based on how you respond and tolerate it.

The maximum is 17.2 mg once daily. The steps beyond 5.5 mg are optional, so the dose you settle on is a decision you make with your prescriber. The dose ladder on this page shows each step, and the titration schedule tool turns it into dates. (Titration just means stepping a dose up slowly.)

How much does Foundayo cost?

Foundayo’s price depends on your dose and on how you pay:

  • LillyDirect self-pay, per 30-day supply: $149 for 0.8 mg, $149 for 2.5 mg, $199 for 5.5 mg, and $299 for 9 mg, 14.5 mg and 17.2 mg.
  • Savings card, if your commercial insurance covers Foundayo: as little as $25 per fill.
  • Savings card, if your commercial insurance doesn’t cover Foundayo: the same by-dose prices as self-pay, from $149 to $299.
  • Medicare GLP-1 Bridge: a $50 monthly copay if you qualify.
  • List price: $649 a month. This is the full price before any discount.

Two conditions sit behind the self-pay prices.

The 2.5 mg and 5.5 mg prices are temporarily reduced through December 31, 2026. Lilly states a higher regular price for those two doses, and that regular price applies after that date unless the offer is extended.

The 14.5 mg and 17.2 mg price is a program price with a refill window. You get it on your first fill at that dose and on refills you buy within 45 days of receiving the previous fill. Refill later and you pay the regular price of $349. The same rule on Zepbound is explained on our 45-day refill rule page, and the supply tracker shows your last on-time date.

TrumpRx lists the same Foundayo prices and sends you to LillyDirect to buy. Several telehealth providers also pass these prices through and charge a membership on top. Ro, for example, lists 0.8 mg at $149 plus a membership of $149 a month after the first month.

Say you start at 0.8 mg and step up every 30 days to 17.2 mg, refilling on time. Your first year through LillyDirect comes to $3,188 at these prices. Our Foundayo cost guide breaks that down, and the cost calculator prices any other path.

What if I miss a dose of Foundayo?

The label has two rules:

  • One missed dose (or a few): take the missed dose as soon as possible. Don’t double up the next dose. With the one-tablet-a-day limit, that means never taking two tablets in the same day.
  • Seven or more doses missed in a row: dose escalation (stepping up) is restarted at a lower dose, to reduce the risk of gastrointestinal (stomach and bowel) side effects.

The label doesn’t say which lower dose to restart at. That’s a decision for your prescriber, not something to work out alone. The missed dose tool applies the label’s rules to your situation and tells you when to call.

A gap can also change what you pay. On 14.5 mg and 17.2 mg, refilling after the window means the regular price.

What are the side effects of Foundayo?

Stomach and bowel effects lead the list. In the label’s pool of Trials 1 and 2 (up to 72 weeks), gastrointestinal reactions were reported by 60 percent of people on 5.5 mg, 68 percent on 9 mg and 69 percent on 17.2 mg, compared with 37 percent on placebo. In the 5.5 mg, 9 mg and 17.2 mg groups versus placebo:

  • Nausea: 26, 34 and 35 percent, versus 10 percent.
  • Constipation: 20, 27 and 24 percent, versus 9 percent.
  • Diarrhea: 21, 23 and 25 percent, versus 11 percent.
  • Vomiting: 13, 21 and 24 percent, versus 4 percent.

Of the people on Foundayo who reported gastrointestinal reactions, the label says 60 percent described them as mild, 36 percent as moderate and 4 percent as severe. Nausea, vomiting and diarrhea were more frequent during dose escalation and decreased over time. Across both trials, 8 percent of people on Foundayo stopped treatment permanently because of adverse reactions (6, 9 and 10 percent across the three doses), compared with 3 percent on placebo.

Headache, fatigue, bloating, belching, reflux and hair loss also appear in the label’s table, which is shown in full on this page.

The boxed warning: thyroid C-cell tumors

Foundayo’s label carries a boxed warning titled “Risk of Thyroid C-Cell Tumors”. It explains that medicines with GLP-1 receptor activity that are active in rats and mice have caused thyroid C-cell tumors in those animals. Orforglipron isn’t pharmacologically active in rats or mice and didn’t produce tumors in rodents. What that means for people taking Foundayo isn’t known.

Foundayo is contraindicated, meaning it must not be used, in anyone with a personal or family history of medullary thyroid carcinoma (MTC), or with multiple endocrine neoplasia syndrome type 2 (MEN 2). It’s also contraindicated in anyone with a known serious hypersensitivity (allergic reaction) to orforglipron or any of the tablet’s ingredients.

Other warnings on the label

The label also warns about acute pancreatitis, severe gastrointestinal reactions, acute kidney injury from dehydration after vomiting or diarrhea, low blood sugar, serious allergic reactions, worsening of diabetic retinopathy in people with type 2 diabetes, acute gallbladder disease, and pulmonary aspiration (stomach contents entering the lungs) during general anesthesia or deep sedation.

If you have type 2 diabetes, the low blood sugar figures are specific. In Trial 2, 7% of patients taking orforglipron with a sulfonylurea reported hypoglycemia (low blood sugar), compared with 0.5% of those not taking a sulfonylurea.

Pregnancy and breastfeeding

The label says weight loss offers no benefit to a pregnant patient and may cause fetal harm, and that Foundayo should be stopped when a pregnancy is recognized. If you could become pregnant, the label advises using effective contraception during treatment. Foundayo isn’t recommended while breastfeeding.

How do I store Foundayo?

Store Foundayo at room temperature, 20°C to 25°C (68°F to 77°F). Short excursions between 15°C and 30°C (59°F and 86°F) are permitted. It doesn’t need a refrigerator, which is one of the practical differences from injectable GLP-1 medicines. The tablets come in a bottle with a desiccant (which absorbs moisture) and a child-resistant cap.

Does insurance or Medicare cover Foundayo?

Commercial insurance

Plans differ on weight-management medicines, and some employers exclude the whole category. Call the number on your insurance card. Ask whether Foundayo is on the formulary (the plan’s list of covered drugs) and whether it needs prior authorization (the plan’s approval before it pays). If it’s covered, the savings card can lower a fill to as little as $25. You can’t use the card if you’re on a government program, and it expires on 12/31/2026.

If your plan says no, your prescriber can submit more information or appeal, and the appeal letter generator drafts a starting letter. In the meantime, you can buy at the self-pay price as a cash purchase outside insurance.

Foundayo and the Medicare GLP-1 Bridge

The Medicare Part D statute excludes drugs when they’re used for weight loss, so a Part D plan won’t normally pay for Foundayo. The Medicare GLP-1 Bridge is a temporary exception. It runs from July 1, 2026 through December 31, 2027, and Foundayo tablets are on its list of covered drugs.

Under the Bridge, if you’re eligible and have Part D coverage, you pay a $50 copay for a one-month supply. The copay is billed outside Part D, so it doesn’t count toward your Part D deductible or out-of-pocket limit, and Extra Help doesn’t reduce it.

To qualify, you must be 18 or older, have Part D drug coverage, and have met the BMI criteria when you first started GLP-1 treatment: a BMI of 35 or higher, or 30 or higher with one of a short list of conditions, or 27 or higher with another. If your Part D plan has already paid for a GLP-1 in 2026, you aren’t eligible, and neither are people with type 2 diabetes. Your prescriber submits one prior authorization, which then covers refills and dose changes through the end of the program.

The Bridge eligibility checker walks through each question, and the Medicare GLP-1 Bridge guide explains the process.

Foundayo vs the Wegovy pill

Two GLP-1 tablets are approved for weight management. Foundayo contains orforglipron and is made by Lilly. The Wegovy pill contains semaglutide and is made by Novo Nordisk. They’re different medicines with separate labels, and no trial on either label compares them directly. Here’s what the labels and the published prices let you compare:

  • How you take each one. Both are once daily. The Wegovy label says to take the tablet in the morning on an empty stomach with up to 4 ounces of water, and to wait at least 30 minutes before eating, drinking or taking other oral medicines. The Foundayo label says with or without food.
  • Strengths. Foundayo: 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, 17.2 mg. Wegovy pill: 1.5 mg, 4 mg, 9 mg, 25 mg.
  • Self-pay price. Foundayo runs from $149 to $299 a month through LillyDirect. The Wegovy pill runs from $149 to $299 a month through NovoCare. Details for the Wegovy pill are in our Wegovy cost guide.
  • Medicare Bridge. Both are covered, at the same copay.

Which one suits you depends on your health history, your other medicines and your coverage. That’s a conversation for your prescriber. To see how a pill compares with pens and vials on cost per fill, use the pen vs vial vs pill comparer.

Foundayo and Zepbound are both Lilly weight-management medicines, but Zepbound is a weekly tirzepatide injection with its own label. The Foundayo label says not to combine it with another GLP-1 receptor agonist.

Where the facts on this page come from

We take each price from the manufacturer’s, the government’s or the provider’s own page, with the wording each one uses, by the method set out in how we verify prices. Label facts come from the FDA label for Foundayo.

Where to get Foundayo

Some links on this page are affiliate links: if you sign up through them we may earn a commission at no extra cost to you. The cheapest legitimate option is always listed first, and payouts never affect rankings. How we make money.

  1. 1. Manufacturer savings card (commercial insurance, drug covered)

    $25 per fill at 17.2 mg

    Tablet (once daily)

    Source: lilly.comGo to the program page

  2. 2. Medicare GLP-1 Bridge

    $50 per fill at 17.2 mg

    Tablet (once daily)

    Source: medicare.govGo to the program page

  3. 3. LillyDirect self-pay

    $299 per fill at 17.2 mg

    Tablet (once daily)

    Source: lilly.comGo to the program page

  4. 4. Manufacturer savings card (commercial insurance, drug not covered)

    $299 per fill at 17.2 mg

    Tablet (once daily)

    Source: lilly.comGo to the program page

  5. 5. TrumpRx

    $299 per fill at 17.2 mg

    Tablet (once daily)

    Source: trumprx.govGo to the program page

Telehealth programs that prescribe Foundayo

At 17.2 mg, these cost more than the options above. They add an online visit with a prescriber and ongoing care.

  • Sesame · $398 per fill including $99 membershipVisit Sesame
  • Ro · $448 per fill including $149 membershipVisit Ro

Ranked by cost only. Manufacturer and government programs never pay us. To see every option for your situation, try the cheapest-path quiz.

Frequently asked questions

What is Foundayo?

Foundayo is the brand name of orforglipron, a GLP-1 receptor agonist made by Eli Lilly that you take as a tablet once a day. The FDA approved it to reduce excess body weight and keep it off long term in adults with obesity, or with overweight and at least one weight-related condition. The label says to use it with a reduced-calorie diet and increased physical activity.

How much does Foundayo cost?

If you pay cash through LillyDirect, a 30-day supply of Foundayo costs $149 for 0.8 mg and 2.5 mg, $199 for 5.5 mg, and $299 for 9 mg, 14.5 mg and 17.2 mg. The list price is $649 a month. If your commercial insurance covers it, the savings card lowers a fill to as little as $25.

What is the brand name of orforglipron?

Foundayo is the brand name of orforglipron. Eli Lilly makes it, and it comes as a once-a-day tablet in six strengths. It's approved for weight reduction in adults with obesity, or with overweight and at least one weight-related condition. It isn't approved for type 2 diabetes.

How do you take Foundayo?

The label says to take one Foundayo tablet by mouth once daily, with or without food. Swallow it whole. Don't break, crush or chew it, and don't take more than one tablet a day. The label doesn't require an empty stomach or a wait before you eat.

What doses does Foundayo come in?

Foundayo comes in six tablet strengths: 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, 17.2 mg. The label starts at 0.8 mg once daily, moves to 2.5 mg after at least 30 days, and then to 5.5 mg after at least 30 more days. From there the dose may go up to 9 mg, 14.5 mg or 17.2 mg, each after at least 30 days, based on how you respond and tolerate it.

What happens if I miss a Foundayo pill?

The label says to take the missed dose as soon as possible and not to double up the next dose, so never take two tablets in one day. If you miss 7 or more doses in a row, the label says to restart dose escalation (stepping up) at a lower dose to reduce the risk of stomach side effects. Your prescriber sets that restart.

Is Foundayo covered by the Medicare GLP-1 Bridge?

Yes. Foundayo tablets are one of the drugs covered by the Medicare GLP-1 Bridge, which runs from July 1, 2026 through December 31, 2027. If you have Medicare Part D and you're eligible, you pay a $50 copay for a one-month supply. Eligibility depends on BMI and health conditions, and your prescriber must submit a prior authorization.

How is Foundayo different from the Wegovy pill?

They're different medicines. Foundayo is orforglipron from Lilly, and the Wegovy pill is semaglutide from Novo Nordisk. You take both once daily. The Wegovy label says to take the tablet in the morning on an empty stomach with a little water and wait at least 30 minutes before eating. The Foundayo label allows it with or without food.

What are the most common side effects of Foundayo?

In the label's two pooled trials, the most common reactions were nausea, constipation, diarrhea, vomiting, dyspepsia (indigestion) and abdominal pain. Nausea was reported by 26 to 35 percent of people on Foundayo, depending on dose, compared with 10 percent on placebo. The label says nausea, vomiting and diarrhea were more frequent while the dose was being increased and decreased over time.

Sources (36)

  1. 1.
    FDA label (DailyMed): Foundayo prescribing information, section 2.1
    “Take FOUNDAYO orally once daily, with or without food.”
  2. 2.
    FDA label (DailyMed): Foundayo prescribing information, section 2.1
    “Swallow tablets whole. Do not break, crush, or chew.”
  3. 3.
    FDA label (DailyMed): Foundayo prescribing information, section 2.1
    “Do not take more than one tablet per day.”
  4. 4.
    FDA label (DailyMed): Foundayo prescribing information, section 2.1
    “The starting dosage is 0.8 mg orally once daily. After at least 30 days on the 0.8 mg dosage, increase the dosage to 2.5 mg once daily.”
  5. 5.
    FDA label (DailyMed): Foundayo prescribing information, section 2.1
    “The maximum dosage of FOUNDAYO is 17.2 mg once daily.”
  6. 6.
    FDA label (DailyMed): Foundayo prescribing information, section 2.3
    “If 7 or more consecutive doses are missed, reinitiate dosage escalation at a lower dosage to reduce the risk of gastrointestinal adverse reactions [see Dosage and Administration (2.1), Warnings and Precautions (5.3), Adverse Reactions (6)].”
  7. 7.
    FDA label (DailyMed): Foundayo Medication Guide (in the prescribing information)
    “Use FOUNDAYO with a reduced-calorie diet and increased physical activity.”
  8. 8.
    FDA label (DailyMed): Foundayo prescribing information, section 16.2
    “Store FOUNDAYO at room temperature 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [See USP Controlled Room Temperature].”
  9. 9.
    FDA label (DailyMed): Foundayo prescribing information, section 8.1
    “Weight loss offers no benefit to a pregnant patient and may cause fetal harm. When a pregnancy is recognized, advise the pregnant patient of the risk to a fetus and discontinue FOUNDAYO.”
  10. 10.
    FDA label (DailyMed): Foundayo prescribing information, section 8.3
    “Advise women of childbearing potential to use effective contraception during treatment with FOUNDAYO.”
  11. 11.
    FDA label (DailyMed): Foundayo prescribing information, section 7.3
    “Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method or add a barrier method of contraception for 30 days after initiation with FOUNDAYO and for 30 days after each dose escalation. Hormonal contraceptives that are not administered orally should not be affected.”
  12. 12.
    FDA label (DailyMed): Foundayo prescribing information, section 8.2
    “FOUNDAYO is not recommended for nursing women.”
  13. 13.
    FDA label (DailyMed): Foundayo prescribing information, section 2.2
    “The maximum dosage of FOUNDAYO is 9 mg once daily when used concomitantly with a strong CYP3A4 inhibitor [see Drug Interactions (7.1), Clinical Pharmacology (12.3)].”
  14. 14.
    FDA label (DailyMed): Foundayo prescribing information, section 2.2
    “Avoid strong CYP3A4 inhibitors that also inhibit OATP1B when taking FOUNDAYO. Avoid strong CYP3A4 inducers when taking FOUNDAYO.”
  15. 15.
    FDA label (DailyMed): Foundayo prescribing information, section 7.2, Table 3
    “Do not exceed simvastatin 20 mg once daily when concomitantly used with FOUNDAYO.”
  16. 16.
    FDA label (DailyMed): Foundayo prescribing information, section 7.3
    “FOUNDAYO delays gastric emptying and thereby has the potential to impact the absorption of concomitantly administered oral medications [see Clinical Pharmacology (12.3)].”
  17. 17.
    FDA label (DailyMed): Foundayo prescribing information, section 7.2, Table 3
    “When initiating FOUNDAYO, consider reducing the dose of concomitantly administered insulin or insulin secretagogues (e.g., sulfonylureas) [see Warnings and Precautions (5.5)].”
  18. 18.
    FDA label (DailyMed): Foundayo prescribing information, section 14
    “In these trials, the primary efficacy parameter was mean percent change in body weight after 72 weeks of treatment.”
  19. 19.
    FDA label (DailyMed): Foundayo prescribing information, section 14
    “This section of labeling presents efficacy data from administration of the investigational orforglipron formulation shown as equivalent dosages of once daily FOUNDAYO [see Dosage and Administration (2.1)].”
  20. 20.
    FDA label (DailyMed): Foundayo prescribing information, section 14, Table 6
    “Table 6: Changes from Baseline in Body Weight at Week 72 in Trials 1 and 2 in Patients with Obesity or Overweight with ≥1 Weight-related Comorbid Condition. % Change from baseline: Trial 1 Placebo once daily N = 949: -2.1; Trial 1 FOUNDAYO 5.5 mg once daily N = 723: -7.4; Trial 1 FOUNDAYO 9 mg once daily N = 725: -8.3; Trial 1 FOUNDAYO 17.2 mg once daily N = 730: -11.1; Trial 2 Placebo once daily N = 630: -2.5; Trial 2 FOUNDAYO 5.5 mg once daily N = 329: -5.1; Trial 2 FOUNDAYO 9 mg once daily N = 332: -7; Trial 2 FOUNDAYO 17.2 mg once daily N = 322: -9.6”
  21. 21.
    FDA label (DailyMed): Foundayo prescribing information, section 1
    “Concomitant use with another GLP-1 receptor agonist is not recommended.”
  22. 22.
    FDA label (DailyMed): Foundayo prescribing information, section 5.3
    “FOUNDAYO is not recommended in patients with severe gastroparesis.”
  23. 23.
    FDA label (DailyMed): Foundayo prescribing information, section 8.6
    “FOUNDAYO is not recommended for use in patients with severe hepatic impairment (Child-Pugh Class C) [see Clinical Pharmacology (12.3)].”
  24. 24.
    FDA label (DailyMed): Foundayo prescribing information, section 8.4
    “Safety and effectiveness of FOUNDAYO have not been established in pediatric patients.”
  25. 25.
    FDA label (DailyMed): Foundayo prescribing information, section 4
    “FOUNDAYO is contraindicated in patients with: A personal or family history of MTC or in patients with MEN 2 [see Warnings and Precautions (5.1)].”
  26. 26.
    FDA label (DailyMed): Foundayo prescribing information, section 4
    “FOUNDAYO is contraindicated in patients with: Known serious hypersensitivity to orforglipron or any of the excipients in FOUNDAYO.”
  27. 27.
    FDA label (DailyMed): Wegovy prescribing information, section 2.1
    “Take one WEGOVY tablet orally once daily on an empty stomach in the morning with water (up to 4 ounces). Do not take WEGOVY tablets with other liquids besides water”
  28. 28.
    FDA label (DailyMed): Wegovy prescribing information, section 2.1
    “After taking a WEGOVY tablet, wait at least 30 minutes before eating food, drinking beverages or taking other oral medications”
  29. 29.
    Federal Register: Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (proposed rule, 89 FR 99340)
    “The statutory definition of a covered Part D drug at section 1860D-2(e)(2) of the Social Security Act (the Act) excludes certain drugs and uses—specifically, those that may be excluded by Medicaid under section 1927(d)(2) of the Act. This includes, at section 1927(d)(2)(A) of the Act, “agents when used for anorexia, weight loss, or weight gain.” Historically, drugs used for weight loss have been excluded from the definition of covered Part D drug, regardless of their use for treatment of individuals with obesity, and have been an optional drug benefit for Medicaid programs.”
  30. 30.
  31. 31.
  32. 32.
  33. 33.
  34. 34.
  35. 35.
  36. 36.